Susser E, Moore R, Link B: Risk factors for homelessness. Epidemiologic Reviews15:546-556,
1993
Susser ES, Lin SP, Conover S: Risk factors for homelessness among patients admitted to a state mental hospital. American Journal of Psychiatry148:1659-1664,
1991
Cohen NL, Putnam JF, Sullivan AM: The mentally ill homeless: isolation and adaptation. Hospital and Community Psychiatry35:922-924,
1984
Padgett DK, Struening EL, Andrews H, et al: Predictors of emergency room use by homeless adults in New York City: the influence of predisposing, enabling, and need factors. Social Science and Medicine41:547-556,
1995
Luder E, Boey E, Buchalter B, et al: Assessment of the nutritional status of urban homeless males. Public Health Reports104:451-457,
1989
Geldberg L, Panarites CJ, Morgenstern H, et al: Tuberculosis skin testing among homeless adults. Journal of General Internal Medicine12:25-33,
1997
Susser E, Miller M, Valencia E, et al: Injection drug use and risk of HIV transmission among homeless men with mental illness. American Journal of Psychiatry153:794-798,
1996
Susser E, Valencia E, Conover S, et al: Preventing recurrent homelessness among mentally ill men: a "critical time" intervention after discharge from a shelter. American Journal of Public Health87:256-262,
1997
Bebout RR, Drake RE, Xie H, et al: Housing status among formerly homeless dually diagnosed adults. Psychiatric Services48:936-941,
1997
Dixon LB, Krauss N, Kernan E, et al: Modifying the PACT model to serve homeless persons with severe mental illness. Psychiatric Services46:684-688,
1995
Leda C, Rosenheck R: Mental health status and community adjustment after treatment in a residential treatment program for homeless veterans. American Journal of Psychiatry149:1219-1224,
1992
Caton CL, Wyatt RJ, Grunberg J, et al: An evaluation of a mental health program for homeless men. American Journal of Psychiatry147:286-289,
1990
Caton CLM: Mental health service use among homeless and never-homeless men with schizophrenia. Psychiatric Services46:1139-1143,
1995
Opler LA, Caton CLM, Shrout P, et al: Symptom profiles and homelessness in schizophrenia. Journal of Nervous and Mental Disease182:174-178,
1994
Drake RE, Wallach MA, Hoffman JS: Housing instability and homelessness among aftercare patients of an urban state hospital. Hospital and Community Psychiatry40:46-51,
1989
Caton CLM, Shrout PE, Dominguez B, et al: Risk factors for homelessness among women with schizophrenia. American Journal of Public Health85:1153-1156,
1995
Appleby L, Desai P: Documenting the relationship between homelessness and psychiatric hospitalization. Hospital and Community Psychiatry36:732-737,
1985
Drake RE, Wallach MA, Teague GB, et al: Housing instability and homelessness among rural schizophrenic patients. American Journal of Psychiatry148:330-336,
1991
Boyer CA, Olfson M, Kellermann SL, et al: Studying inpatient treatment practice in schizophrenia: an integrated methodology. Psychiatric Quarterly66:293-320,
1995
Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R: Patient Education (SCID-P, Version 1.0). Washington, DC, American Psychiatric Association, 1990
Overall JE, Gorham DP: Brief Psychiatric Rating Scale. Psychological Reports10:799-807,
1962
Endicott J, Spitzer RL, Fleiss JL, et al: The Global Assessment Scale. Archives of General Psychiatry33:766-771,
1976
Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement1:385-401,
1977
Sheehan D, Janavs J, Knapp E, et al: Mini-International Neuropsychiatric Interview, Clinical Rated, Version 4.0, Tampa, University of South Florida College of Medicine, 1992
Sheehan DV, Lecrubier Y, Janavs J, et al: Reliability and validity of the Mini-International Neuropsychiatric Interview (MINI) according to the SCID-P. Presented at the New Clinical Drug Evaluation annual meeting, Orlando, Fla, May 31, 1995
Guy W: ECDEU Assessment Manual for Psychopharmacology, rev ed. Washington, DC, US Department of Health, Education, and Welfare, 1976
Haywood TW, Kravits HM, Grossman LS, et al: Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry152:856-861,
1995
Negroid J, Knoop WP, Douglas DE, et al: Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine16:515-520,
1986
Valenica E, Susser E, McQuistion H: Critical time points in the clinical care of homeless mentally ill individuals, in Practicing Psychiatry in the Community: A Manual. Edited by Vaccaro JV, Clarke GH Jr. Washington, DC, American Psychiatric Press, 1996
Jones K, Colson P, Valencia E, et al: A preliminary cost-effectiveness analysis of an intervention to reduce homelessness among the mentally ill. Psychiatric Quarterly65:243-256,
1994
Tollefson GD, Beasley CM, Street JS, et al: Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry154:457-465,
1997
Hoyberg OJ, Fensbo C, Remvig J, et al: Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations. Acta Psychiatrica Scandinavica88:395-402,
1993
Hagger C, Buckley P, Kenny JT, et al: Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry34:702-712,
1993